LFDLE
BMRN icon

La Financiere de L'Echiquier’s BioMarin Pharmaceuticals BMRN Stock Holding History

La Financiere de L'Echiquier’s Portfolio BMRN Stock Details BMRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		$321K Sell
3,900
-300
-7% -$25K 0.01% 95
2024
Q1 		$367K Buy
4,200
+200
+5% +$17.9K 0.02% 92
2023
Q4 		$386K Buy
4,000
+400
+11% +$35.4K 0.02% 92
2023
Q3 		$319K Buy
+3,600
New +$320K 0.02% 97

Other funds holding BMRN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

La Financiere de L'Echiquier's BMRN Position: Q2 2024 in Review

La Financiere de L'Echiquier reduced its BioMarin Pharmaceuticals (BMRN) stake by 7.1% in Q2 2024, selling an estimated $25K and leaving 3,900 shares worth $321K. The position accounts for 0.01% of the portfolio, ranked #95.

La Financiere de L'Echiquier first reported a position in BMRN in Q3 2023 and has held it in 4 quarters since. The position peaked at $386K in Q4 2023. 559 funds tracked by Wall St. Rank hold BMRN as of Q2 2024.

  • La Financiere de L'Echiquier held 3,900 shares of BioMarin Pharmaceuticals worth $321K as of Q2 2024.
  • La Financiere de L'Echiquier sold 300 BioMarin Pharmaceuticals shares in Q2 2024, an estimated $25K.
  • BioMarin Pharmaceuticals made up 0.01% of La Financiere de L'Echiquier's portfolio in Q2 2024, its #95 holding.
  • La Financiere de L'Echiquier first reported a position in BioMarin Pharmaceuticals in Q3 2023 and has held it in 4 quarters since.
  • La Financiere de L'Echiquier's BioMarin Pharmaceuticals position peaked at $386K in Q4 2023.
  • 559 funds tracked by Wall St. Rank held BioMarin Pharmaceuticals as of Q2 2024.

Based on La Financiere de L'Echiquier's 13F filing for Q2 2024, filed 18 Jul 2024.